MRK DEF 14A DEF-14A Report April 13, 2015 | Alphaminr
Merck & Co., Inc.

MRK DEF 14A Report ended April 13, 2015

MERCK & CO., INC.
10-Ks and 10-Qs
10-Q
Quarter ended Sept. 30, 2024
10-Q
Quarter ended June 30, 2024
10-Q
Quarter ended March 31, 2024
10-K
Fiscal year ended Dec. 31, 2023
10-Q
Quarter ended Sept. 30, 2023
10-Q
Quarter ended June 30, 2023
10-Q
Quarter ended March 31, 2023
10-K
Fiscal year ended Dec. 31, 2022
10-Q
Quarter ended Sept. 30, 2022
10-Q
Quarter ended June 30, 2022
10-Q
Quarter ended March 31, 2022
10-K
Fiscal year ended Dec. 31, 2021
10-Q
Quarter ended Sept. 30, 2021
10-Q
Quarter ended June 30, 2021
10-Q
Quarter ended March 31, 2021
10-K
Fiscal year ended Dec. 31, 2020
10-Q
Quarter ended Sept. 30, 2020
10-Q
Quarter ended June 30, 2020
10-Q
Quarter ended March 31, 2020
10-K
Fiscal year ended Dec. 31, 2019
10-Q
Quarter ended Sept. 30, 2019
10-Q
Quarter ended June 30, 2019
10-Q
Quarter ended March 31, 2019
10-K
Fiscal year ended Dec. 31, 2018
10-Q
Quarter ended Sept. 30, 2018
10-Q
Quarter ended June 30, 2018
10-Q
Quarter ended March 31, 2018
10-K
Fiscal year ended Dec. 31, 2017
10-Q
Quarter ended Sept. 30, 2017
10-Q
Quarter ended June 30, 2017
10-Q
Quarter ended March 31, 2017
10-K
Fiscal year ended Dec. 31, 2016
10-Q
Quarter ended Sept. 30, 2016
10-Q
Quarter ended June 30, 2016
10-Q
Quarter ended March 31, 2016
10-K
Fiscal year ended Dec. 31, 2015
10-Q
Quarter ended Sept. 30, 2015
10-Q
Quarter ended June 30, 2015
10-Q
Quarter ended March 31, 2015
10-K
Fiscal year ended Dec. 31, 2014
10-Q
Quarter ended Sept. 30, 2014
10-Q
Quarter ended June 30, 2014
10-Q
Quarter ended March 31, 2014
10-K
Fiscal year ended Dec. 31, 2013
10-Q
Quarter ended Sept. 30, 2013
10-Q
Quarter ended June 30, 2013
10-Q
Quarter ended March 31, 2013
10-K
Fiscal year ended Dec. 31, 2012
10-Q
Quarter ended Sept. 30, 2012
10-Q
Quarter ended June 30, 2012
10-Q
Quarter ended March 31, 2012
10-K
Fiscal year ended Dec. 31, 2011
10-Q
Quarter ended Sept. 30, 2011
10-Q
Quarter ended June 30, 2011
10-Q
Quarter ended March 31, 2011
10-K
Fiscal year ended Dec. 31, 2010
10-Q
Quarter ended Sept. 30, 2010
10-Q
Quarter ended June 30, 2010
10-Q
Quarter ended March 31, 2010
10-K
Fiscal year ended Dec. 31, 2009
PROXIES
DEF 14A
Filed on April 11, 2024
DEF 14A
Filed on April 3, 2023
DEF 14A
Filed on April 4, 2022
DEF 14A
Filed on April 5, 2021
DEF 14A
Filed on April 6, 2020
DEF 14A
Filed on April 8, 2019
DEF 14A
Filed on April 9, 2018
DEF 14A
Filed on April 10, 2017
DEF 14A
Filed on April 11, 2016
DEF 14A
Filed on April 13, 2015
DEF 14A
Filed on April 14, 2014
DEF 14A
Filed on April 15, 2013
DEF 14A
Filed on April 12, 2012
DEF 14A
Filed on April 13, 2011
DEF 14A
Filed on April 12, 2010
TABLE OF CONTENTS
Voting InformationProxy SummaryNotice of Annual Meeting of ShareholdersCorporate GovernanceBoards Role in Strategic PlanningIndependence of DirectorsBoard Leadership StructureLead DirectorSuccession PlanningAnnual Board EvaluationRisk OversightRelated Person TransactionsBoard Meetings and CommitteesShareholder EngagementShareholder Communications with the BoardPolitical Contributions and Lobbying Expenditure Oversight and DisclosureCommitment to Corporate ResponsibilityStock Ownership InformationSection 16(a) Beneficial Ownership Reporting ComplianceProposal 1: Election of DirectorsCriteria and Director Nomination Process2015 Nominees for DirectorDirector CompensationProposal 2. Non-Binding Advisory Vote to Approve the Compensation of our Named Executive OfficersCompensation Discussion and AnalysisExecutive SummaryResults of 2014 Shareholder Advisory VotePay for Performance AlignmentUnderstanding the Increase in Disclosed CompensationKey 2015 Compensation ActionsCompensation Policies and PracticesDetailed Discussion and AnalysisThe Elements of 2014 CompensationExecutive Compensation Program Objectives and StrategyCompensation Risk AssessmentCompensation and Benefits Committee ReportSummary Compensation TableGrants of Plan-Based AwardsOutstanding Equity AwardsOption Exercises and Stock VestedPension BenefitsNonqualified Deferred CompensationPotential Payments Upon Termination or a Change in ControlProposal 3. Ratification of Appointment of Independent Registered Public Accounting Firm for 2015Audit Committees ReportPre-Approval Policy for Services of Independent Registered Public Accounting FirmFees for Services Provided by Independent Registered Public Accounting FirmProposal 4. Proposal to Amend and Restate the 2010 Incentive Stock PlanProposal 5. Proposal to Amend and Restate the Executive Incentive PlanShareholder ProposalsProposal 6. Shareholder Proposal Concerning Shareholders Right to Act by Written ConsentProposal 7. Shareholder Proposal Concerning Accelerated Vesting of Equity AwardsQuestions and Answers About the Annual Meeting and VotingRequirements For Submitting Proxy Proposals and Transaction of Business at Annual MeetingDate for Receipt of Shareholder Proposals for Inclusion in the Proxy Statement for the 2016 Annual Meeting of ShareholdersProcedure for Transaction of Business at Annual MeetingForward Looking StatementsOther MattersAppendix A - Merck & Co., Inc. 2010 Incentive Stock Plan A-1Appendix B - Merck & Co., Inc. Executive Incentive Plan B-1